CM
ORIC icon

Caption Management’s Oric Pharmaceuticals ORIC Stock Holding History

Caption Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-996,200
Closed -$10.1M – 1946
2025
Q2 		$10.1M Buy
+996,200
New +$6.69M 0.11% 202
2025
Q1 		– Sell
-135,000
Closed -$1.09M – 1897
2024
Q4 		$1.09M Buy
+135,000
New +$1.24M 0.01% 890
2024
Q1 		– Sell
-200,000
Closed -$1.84M – 1557
2023
Q4 		$1.84M Buy
+200,000
New +$1.45M 0.02% 642

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Caption Management's ORIC Position: Q4 2025 in Review

Caption Management sold out of Oric Pharmaceuticals (ORIC) in Q4 2025, closing a stake of 49,389 shares — an estimated $593K sold.

Caption Management first reported a position in ORIC in Q2 2023 and held it in 4 quarters. The position peaked at $876K in Q4 2023. 164 funds tracked by Wall St. Rank hold ORIC as of Q4 2025.

  • Caption Management reported no remaining Oric Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Caption Management sold 49,389 Oric Pharmaceuticals shares in Q4 2025, an estimated $593K.
  • Caption Management first reported a position in Oric Pharmaceuticals in Q2 2023 and held it in 4 quarters.
  • Caption Management's Oric Pharmaceuticals position peaked at $876K in Q4 2023.
  • 164 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2025.

Based on Caption Management's 13F filing for Q4 2025, filed 17 Feb 2026.